A turning point in the fight against ovarian cancer?

Lancet Oncol. 2018 Feb;19(2):154-156. doi: 10.1016/S1470-2045(18)30005-6. Epub 2018 Jan 18.

Authors

Giovanni Scambia¹, Gabriella Ferrandina²

Affiliations

¹ Department of Woman and Child Health, Woman Health Area, Gynecologic Oncology Unit Fondazione "Policlinico Universitario A Gemelli", Catholic University, Rome 00168, Italy. Electronic address: giovanni.scambia@policlinicogemelli.it.
² Department of Woman and Child Health, Woman Health Area, Gynecologic Oncology Unit Fondazione "Policlinico Universitario A Gemelli", Catholic University, Rome 00168, Italy.

PMID: 29361471
DOI: 10.1016/S1470-2045(18)30005-6

No abstract available

Publication types

Comment

MeSH terms

Cell Cycle Checkpoints
Checkpoint Kinase 1
Female
Humans
Ovarian Neoplasms*
Pyrazines*
Pyrazoles

Substances

Pyrazines
Pyrazoles
prexasertib
Checkpoint Kinase 1